Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBIT: 2014-2025

Historic EBIT for Ocugen (OCGN) over the last 11 years, with Sep 2025 value amounting to -$17.6 million.

  • Ocugen's EBIT fell 33.00% to -$17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.8 million, marking a year-over-year decrease of 13.96%. This contributed to the annual value of -$54.8 million for FY2024, which is 16.44% up from last year.
  • As of Q3 2025, Ocugen's EBIT stood at -$17.6 million, which was down 27.76% from -$13.8 million recorded in Q2 2025.
  • In the past 5 years, Ocugen's EBIT registered a high of -$7.1 million during Q1 2021, and its lowest value of -$25.6 million during Q2 2021.
  • Moreover, its 3-year median value for EBIT was -$13.8 million (2024), whereas its average is -$15.1 million.
  • In the last 5 years, Ocugen's EBIT plummeted by 660.84% in 2021 and then spiked by 50.65% in 2023.
  • Quarterly analysis of 5 years shows Ocugen's EBIT stood at -$14.6 million in 2021, then plummeted by 60.27% to -$23.4 million in 2022, then surged by 50.65% to -$11.5 million in 2023, then fell by 20.09% to -$13.8 million in 2024, then plummeted by 33.00% to -$17.6 million in 2025.
  • Its EBIT was -$17.6 million in Q3 2025, compared to -$13.8 million in Q2 2025 and -$14.5 million in Q1 2025.